sellWeak cluster of 4
Steven Weber sold $4,032 of IGMS
PRINCIPAL ACCOUNTING OFFICER at IGM Biosciences, Inc.. 539 shares at an average of $7.48, traded Dec 16, 2024, filed Dec 18, 2024.
Warning score
30Value
$4,032
539 shares
Holdings after
31,704
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- 0Share of holdings soldSold 1.7% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-029779, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | SOpen-market sale Common Stock | -539 | $7.48 | $4,032 | 31,704 | Dec 18, 2024 |
Related signals
Other insiders at IGM Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | IGM Biosciences, Inc. | Lisa Lynn Decker CHIEF BUSINESS OFFICER | $5,612 4,409 shares | -6% | |
| 40Moderate | IGM Biosciences, Inc. | Mary Beth Harler Chief Executive Officer | $18k 14,501 shares | -4% | |
| 37Weak | IGM Biosciences, Inc. | Misbah Tahir CHIEF FINANCIAL OFFICER | $11k 8,741 shares | -5% | |
| 30Weak | IGM Biosciences, Inc. | Lisa Lynn Decker CHIEF BUSINESS OFFICER | $1,140 951 shares | -1% | |
| 40Moderate | IGM Biosciences, Inc. | Mary Beth Harler Chief Executive Officer | $1,825 1,522 shares | -0% | |
| 37Weak | IGM Biosciences, Inc. | Misbah Tahir CHIEF FINANCIAL OFFICER | $1,825 1,522 shares | -1% | |
| 30Weak | IGM Biosciences, Inc. | Steven Weber PRINCIPAL ACCOUNTING OFFICER | $583 486 shares | -2% | |
| 15Weak | IGMSsell IGM Biosciences, Inc. | Steven Weber PRINCIPAL ACCOUNTING OFFICER | $2,090 1,865 shares | -6% | |
| 30Weak | IGM Biosciences, Inc. | Lisa Lynn Decker CHIEF BUSINESS OFFICER | $5,550 4,512 shares | -6% | |
| 40Moderate | IGM Biosciences, Inc. | Mary Beth Harler Chief Executive Officer | $9,015 7,329 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.